Histone 3 lysine 27 trimethylation in type 2 diabetes: a novel potential pharmacological target in diabetic foot ulcer treatment

Back

ESC Premium Access

Histone 3 lysine 27 trimethylation in type 2 diabetes: a novel potential pharmacological target in diabetic foot ulcer treatment

Session: Improving diabetes outcomes: beyond glucocentricity

Topic: Diabetes, dysglycaemia and metabolic syndrome

Speaker: Doctor M. Colognesi-Capogrossi (Rome, IT)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Maurizio Colognesi-Capogrossi

Dermopathic Institute of the Immaculate Conception-IRCCS (I.D.I.), Rome (Italy)

0 follower

7 more presentations in this session

Excess risk of heart failure among persons with type 2 diabetes

Speaker: Professor A. Rosengren (Gothenburg, SE)

Efficacy and safety of didpeptidyl peptidase 4 inhibitors and sodium-glucose linked cotransporter-2 inhibitors in patients with type 2 diabetes mellitus: a meta-analysis

Speaker: Doctor G. Savarese (Stockholm, SE)

Impact of pioglitazone on cardiovascular events in patients with type-II diabetes mellitus after drug-eluting stent implantation

Speaker: Doctor H. Yokoi (Fukuoka, JP)

Nephro-protective effects of Dapagliflozin in patients with type 2 diabetes

Speaker: Doctor M. Nakayama (Tokyo, JP)

Impact of the presence and treatment status of diabetes on long-term mortality following coronary angiography

Speaker: Doctor B. Zafrir (Haifa, IL)

Access the full session

Improving diabetes outcomes: beyond glucocentricity

Speakers: Doctor M. Colognesi-Capogrossi, Professor A. Rosengren, Doctor G. Savarese, Doctor H. Yokoi, Doctor M. Nakayama...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources